Literature DB >> 25798688

In vitro effects of some flavonoids and phenolic acids on human pyruvate kinase isoenzyme M2.

Erdem Aslan1, Caglar Guler1, Sevki Adem1.   

Abstract

Pyruvate kinase isoenzyme M2 (PKM2) is one of the most important control point enzyme in glycolysis pathway. Hence, its inhibitors and activators are currently considered as the potential anticancer agents. The effect of 28 polyphenolic compounds on the enzyme activity was investigated in vitro. Among these compounds, neoeriocitrin, (-)-catechin gallate, fisetin, (±)-taxifolin and (-)-epicatechin have the highest inhibition effect with IC50 value within 0.65-1.33 µM range. Myricetin and quercetin 3-β-D-glucoside exhibited the highest activation effect with 0.51 and 1.34 µM AC50 values, respectively. Twelve of the compounds showed inhibition effect within 7-38 µM range of IC50 value. Sinapinic acid and p-coumaric acid showed an activation effect with 26.2 and 22.2 µM AC50 values, respectively. The results propose that the polyphenolics may be the potential PKM2 inhibitors/activators, and they may be used as lead compounds for the synthesis of new inhibitors or activators of this enzyme.

Entities:  

Keywords:  Activation; PKM2; cancer; flavonoid; inhibition; phenolic acid

Mesh:

Substances:

Year:  2015        PMID: 25798688     DOI: 10.3109/14756366.2015.1022173

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  4 in total

1.  V8 induces apoptosis and the endoplasmic reticulum stress response in human multiple myeloma RPMI 8226 cells via the PERK-eIF2α-ATF4 signaling pathway.

Authors:  Yaping Zhong; Yonggang Zhang; Ping Wang; Hongxiu Gao; Chunling Xu; Hui Li
Journal:  Oncol Lett       Date:  2016-08-12       Impact factor: 2.967

Review 2.  Flavonoids Targeting HIF-1: Implications on Cancer Metabolism.

Authors:  Marek Samec; Alena Liskova; Lenka Koklesova; Sandra Mersakova; Jan Strnadel; Karol Kajo; Martin Pec; Kevin Zhai; Karel Smejkal; Sepideh Mirzaei; Kiavash Hushmandi; Milad Ashrafizadeh; Luciano Saso; Aranka Brockmueller; Mehdi Shakibaei; Dietrich Büsselberg; Peter Kubatka
Journal:  Cancers (Basel)       Date:  2021-01-03       Impact factor: 6.639

Review 3.  Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies.

Authors:  Yi Zhang; Qiong Li; Zhao Huang; Bowen Li; Edouard C Nice; Canhua Huang; Liuya Wei; Bingwen Zou
Journal:  Cancers (Basel)       Date:  2022-09-21       Impact factor: 6.575

Review 4.  Tumor pyruvate kinase M2 modulators: a comprehensive account of activators and inhibitors as anticancer agents.

Authors:  Bhagyashri Rathod; Shivam Chak; Sagarkumar Patel; Amit Shard
Journal:  RSC Med Chem       Date:  2021-05-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.